Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
LONG BEACH, Calif. — Senate Majority Leader Mitch McConnell, a longtime opponent of reforming marijuana laws, is spending more time than usual thinking about cannabis on a trip to California this week.
McConnell is attending at least two days’ worth of meetings with cannabis industry executives, small-business owners and advocates in Southern California, in order to discuss potential cannabis-related banking reform, among other topics, according to people familiar with the matter. McConnell’s schedule includes two cannabis-related lunches with executives and advocates, one of which will take place in Newport Beach, Calif., and a tour of at least one cannabis-related company in the area.
It was not immediately clear whether McConnell’s California Wednesday and Thursday schedule signals a shift in his thinking about cannabis banking reform, the people said. McConnell’s Washington office did not respond to several requests for comment.
Read: Cannabis companies have secret formulas to determine when the U.S. may allow pot sales
“I think this is absolutely positive that McConnell is meeting with stakeholders in the cannabis market,” PI Financial analyst Jason Zandberg told MarketWatch over the phone. “The U.S. market needs the banking act to flourish, without it — there are legitimate companies that are following the rules that are facing major obstacles. Banking legislation would be a huge positive catalyst.”
The cannabis industry representatives will attempt to convince McConnell that reform is necessary because the current legal regime unfairly penalizes businesses that obey federal laws, such as hemp farmers producing the crop for legal CBD products, according to a person familiar with the lobbying strategy.
“We’re happy to see that Leader McConnell is coming to see how a regulated market is an improvement over prohibition,” National Cannabis Industry Association executive director Aaron Smith told MarketWatch in an interview. “Right now the priority is banking, which affects [McConnell’s] constituents in the hemp and CBD industry, as well as legal cannabis businesses here in California. That’s really our primary ask — common-sense policies around banking and public safety, and we’re hopeful [McConnell] will see the need for that and move forward along with Chairman [Sen. Mike] Crapo.”
The senator’s visit to the Golden State comes weeks after the Democratic-controlled House of Representatives passed the Secure and Fair Enforcement (SAFE) Banking Act, a bill aimed at giving banks and credit unions additional clarity around servicing cannabis companies that wish to open accounts for things like paying bills. Because marijuana is illegal at the federal level, financial institutions can encounter legal problems, and cannabis companies — including those that operate cannabidiol, or CBD, businesses — face difficulties banking.
Large amounts of cash sloshing around the cannabis sector makes pot companies the target of robberies and other crimes, lobbyists in favor of the SAFE Act have said.
Up until recently, McConnell appeared to be a major roadblock to the Senate taking up the bill, and has said in the past that marijuana is hemp’s “illicit cousin, which I choose not to embrace.” The hemp industry holds a significant amount of power in Kentucky, McConnell’s home state, and a new provision in the SAFE Act grants specific protections to hemp farmers.
Check out: Cannabis Watsh — All of MarketWatch’s coverage of cannabis companies
Don’t miss: Cannabis industry’s lobbying on track to hit a new record
Crapo, an influential Republican senator from Idaho, told Politico in September that he wanted to hold a Senate Banking Committee vote on a cannabis banking bill. Progressive groups such as the American Civil Liberties Union, the Center for American Progress and others have criticized top House Democrats for moving forward with a bill that doesn’t address social-justice issues tied to decades of cannabis prohibition.
ETFMG Alternative Harvest ETF MJ, -0.95% , which tracks a basket of cannabis stocks, has lost nearly half its value in the past 12 months, while the broad S&P 500 index SPX, +0.91% has gained 1.6%.
Additional reporting by Victor Reklaitis
LONG BEACH, Calif. — Senate Majority Leader Mitch McConnell, a longtime opponent of reforming marijuana laws, is spending more time than usual thinking about cannabis on a trip to California this week.
McConnell is attending at least two days’ worth of meetings with cannabis industry executives, small-business owners and advocates in Southern California, in order to discuss potential cannabis-related banking reform, among other topics, according to people familiar with the matter. McConnell’s schedule includes two cannabis-related lunches with executives and advocates, one of which will take place in Newport Beach, Calif., and a tour of at least one cannabis-related company in the area.
It was not immediately clear whether McConnell’s California Wednesday and Thursday schedule signals a shift in his thinking about cannabis banking reform, the people said. McConnell’s Washington office did not respond to several requests for comment.
Read: Cannabis companies have secret formulas to determine when the U.S. may allow pot sales
“I think this is absolutely positive that McConnell is meeting with stakeholders in the cannabis market,” PI Financial analyst Jason Zandberg told MarketWatch over the phone. “The U.S. market needs the banking act to flourish, without it — there are legitimate companies that are following the rules that are facing major obstacles. Banking legislation would be a huge positive catalyst.”
The cannabis industry representatives will attempt to convince McConnell that reform is necessary because the current legal regime unfairly penalizes businesses that obey federal laws, such as hemp farmers producing the crop for legal CBD products, according to a person familiar with the lobbying strategy.
“We’re happy to see that Leader McConnell is coming to see how a regulated market is an improvement over prohibition,” National Cannabis Industry Association executive director Aaron Smith told MarketWatch in an interview. “Right now the priority is banking, which affects [McConnell’s] constituents in the hemp and CBD industry, as well as legal cannabis businesses here in California. That’s really our primary ask — common-sense policies around banking and public safety, and we’re hopeful [McConnell] will see the need for that and move forward along with Chairman [Sen. Mike] Crapo.”
The senator’s visit to the Golden State comes weeks after the Democratic-controlled House of Representatives passed the Secure and Fair Enforcement (SAFE) Banking Act, a bill aimed at giving banks and credit unions additional clarity around servicing cannabis companies that wish to open accounts for things like paying bills. Because marijuana is illegal at the federal level, financial institutions can encounter legal problems, and cannabis companies — including those that operate cannabidiol, or CBD, businesses — face difficulties banking.
Large amounts of cash sloshing around the cannabis sector makes pot companies the target of robberies and other crimes, lobbyists in favor of the SAFE Act have said.
Up until recently, McConnell appeared to be a major roadblock to the Senate taking up the bill, and has said in the past that marijuana is hemp’s “illicit cousin, which I choose not to embrace.” The hemp industry holds a significant amount of power in Kentucky, McConnell’s home state, and a new provision in the SAFE Act grants specific protections to hemp farmers.
Check out: Cannabis Watsh — All of MarketWatch’s coverage of cannabis companies
Don’t miss: Cannabis industry’s lobbying on track to hit a new record
Crapo, an influential Republican senator from Idaho, told Politico in September that he wanted to hold a Senate Banking Committee vote on a cannabis banking bill. Progressive groups such as the American Civil Liberties Union, the Center for American Progress and others have criticized top House Democrats for moving forward with a bill that doesn’t address social-justice issues tied to decades of cannabis prohibition.
ETFMG Alternative Harvest ETF MJ, -0.95% , which tracks a basket of cannabis stocks, has lost nearly half its value in the past 12 months, while the broad S&P 500 index SPX, +0.91% has gained 1.6%.
Additional reporting by Victor Reklaitis
Close
Print
AURORA CANNABIS INC (CA: ACB)
Real-time
Last: 12.09 Change: 0.00 Volume: 0 Last Trade: 03/29
News Story
Hemp CBD Uses Proving to be Endless Opportunities for Cannabis Stocks
01 Apr 2019 08:45 ET
CNW Group
A recent article in CannabizDaily, an industry newsletter, focused on the reasons hemp biomass, although not a 'sexy' label. can be the source of significant revenues in the ever-expanding industry. It said: "It turns out that hemp not only gives us medical and recreational cannabis products, but it also gives us bio-fuel. According to research, hemp can be one of the bio-fuels of the future. Recent developments related to hemp production have shown that hemp can be used as an additive to food products like breads, pasta, milk, and cake mixes. But it doesn't stop there. Hemp has also been found to be a good source of fuel. Hemp is regarded valuable to the energy sector because its by-products can provide alternative fuels. Hemp specifically falls under a fuel classification that is called biomass. Biomass is a term for the organic matter that can be converted into and used as fuel, and is thus considered as a potential renewable energy source." The article continued: "Australian hemp advocate Klara Marosszeky said that growing hemp is a great sustainable alternative for small farmers. Not to mention that it is also great for the environment. According to her, biomass produced by hemp is equivalent to the same area of forest per year, but it is produced in a four-month growth period." Active Companies from around the market with current developments this week include: Marijuana Company of America, Inc. (OTC:MCOA), PotNetwork Holdings, Inc. (OTC:POTN), Cannabis Science, Inc. (OTC: CBIS), Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB), HEXO Corp. (NYSE: HEXO) (TSX: HEXO).
According to Marosszeky , "Hemp biomass is processed into fuel through biological digestion or chemical decomposition. The waste from hemp cannabis plant is taken and is transformed into a carbon nanomaterial. This carbon nanomaterial can be used as substitute for the more expensive graphene, which is a nanomaterial that is used in high-power super capacitors and batteries. Super capacitors are used in the fast-charging batteries for electronics like laptops, smartphones, and vehicle braking systems."
Marijuana Company of America, Inc. (OTCQB:MCOA) BREAKING NEWS: Marijuana Company of America, an innovative hemp and cannabis corporation, and its Joint Venture partner Global Hemp Group (CSE: GHG/ OTC: GBHPF/ FRA: GHG) (together with the Company, the "Partners") are pleased to announce that they are currently in negotiations with several cannabinoid extraction companies in Oregon, USA, regarding the acquisition of the joint venture's hemp biomass produced at the Scio farm from the 2018 harvest. The team at the Scio farm has prepared processing samples ranging in size from 100 lbs to 2,000 lbs. for the extraction companies. The biomass is being processed into CBD crude oil with the option to refine it further into isolate, or full spectrum oil, in order to increase its value on the market. Results from the current extraction test batches are expected to be received by mid-April and will serve as a basis for the final terms of the sale of the biomass by the Partners.
Cloning Update - The cloning process is well underway at the Scio farm. For this year's cultivation, four different strains have been chosen from the latest high CBD industrial hemp varieties, which are being used as a base for the in-house propagation program. The goal of the program is to produce approximately 50,000 clones to populate the lower 35 acres of the Scio farm for the 2019 season, and reduce and/or eliminate the need for the acquisition of any additional seeds or clones from outside sources. The program started with 400 high quality plants. Through a regimen of proper nutrients and a controlled environment, these "mother" plants will grow into very large bushes, which will be used to derive a sufficient number of clones, ensuring that the target number of plants required for this year's cultivation is reached. Once removed from the mother plants, the clones will then be placed in a propagation greenhouse to root. Once rooted and well established, the clones will then be ready to be planted in the fields, which is expected to begin this year in late May or early June.
Expansion in 2019 - The Company continues to evaluate a number of opportunities to expand the scope of its project in Oregon. As previously announced, a number of local farmers are interested in working with the joint venture partners to grow hemp in 2019. The Oregon Department of Agriculture expects hemp cultivation in Oregon to grow from 11,514 acres in 2018 to more than 25,000 in this current year. In order for new hemp farmers to be successful, they will need to rely on experienced hemp farming teams like our Scio farm team. This will create potential opportunity to joint venture with the local farming community.
Micropropagation (Tissue Culture) - The Company has begun preliminary exploration to expand its business into micropropagation of hemp plants. By focusing on culturing the tissue from feminized "mother" hemp plants that are proven to produce high CBD levels, the Company believes it can more efficiently provide plants with higher-yielding and more profitable CBD content. Micropropagation techniques rely on uniform tissue sampling from high yielding CBD feminized hemp plants, that is more effective than developing plants from the more traditional methods of germination from seed or cloning from other plants. Read this and more news for MCOA at: https://www.financialnewsmedia.com/news-mcoa/
In the industry developments and happenings in the market this week include:
PotNetwork Holdings, Inc. (OTCPK:POTN), the publisher of PotNetwork News and PotNetwork, the magazine recently announced that PotNetwork News, the cannabis industry's premier outlet for financial, political, and trade news, launched a new streamlined website that now includes business listings, an industry events calendar, detailed marijuana stock market quotes, and a dedicated page where users can find all of PotNetwork News' latest video reports. Cannabis enthusiasts are invited to register with the site so they can keep up with the latest news and more in the cannabis industry.
"We are excited about embarking on this new era here at PotNetwork News," said Brandon A. Dorfman, Editor-in-Chief of PotNetwork News. "We see ourselves growing into both the LinkedIn and the CNBC of the cannabis space, a one-stop shop for all your information needs."
Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the Company has expanded into the Canadian market with the formation of Cannabis Science Canada, Inc. Cannabis Science Canada Inc. is a wholly-owned subsidiary of Cannabis Science Inc., and has already begun negotiations for Canadian land, licenses, and expansion capital. "Establishing a presence in Canada is strategically important for Cannabis Science! We can all see the immediate opportunity within its burgeoning cannabis medical industry, and its financial foray; the timing could not be better for us!" stated Mr. Raymond C. Dabney, Cannabis Science's President, CEO, and Co-founder.
Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) recently announced that the Company and its wholly-owned subsidiary CanniMed Therapeutics, have added product information numbers (PINs) to 78 medical cannabis products to better facilitate and track insurance coverage for their Canadian patients. The products that received PINs include dried flower, capsules, soft gels, topicals and oils.
PINs help employers and insurance companies classify and incorporate health care products into benefit coverage plans. Patients submitting claims to their third-party insurer can now identify specific products and thereby speed up the adjudication and medical coverage process. MedReleaf, another wholly-owned subsidiary of Aurora, introduced PINs to 57 medical cannabis products in 2018.
HEXO Corp. (NYSE-A: HEXO) (TSX: HEXO) and Newstrike Brands Ltd. ("Newstrike") (HIP.V) recently announced that they have entered into a definitive arrangement agreement (the "Arrangement Agreement") under which HEXO will acquire, by way of a plan of arrangement under the Business Corporations Act (Ontario), all of Newstrike's issued and outstanding common shares in an all-share transaction valued at approximately $263 million (the "Transaction").
Under the terms of the Arrangement Agreement, Newstrike shareholders will receive 0.06332 of a HEXO common share in exchange for each Newstrike common share held.
DISCLAIMER: FN Media Group LLC (FNM), which owns and operates Financialnewsmedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with any company mentioned herein. FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNM is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNM expects to be compensated forty six hundred dollars for news coverage of the current press release issued by Marijuana Company of America, Inc. by a non-affiliated third party. FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.
Contact Information:Media Contact email: editor@financialnewsmedia.com +1(561)325-8757
View original content:http://www.prnewswire.com/news-releases/hemp-cbd-uses-proving-to-be-endless-opportunities-for-cannabis-stocks-300821604.html
SOURCE Financialnewsmedia.com
View original content: http://www.newswire.ca/en/releases/archive/April2019/01/c5719.html
SOURCE: Financialnewsmedia.com
Copyright (C) 2019 CNW Group. All rights reserved.
Chart not available
Important Legal Notice: All market data is provided by a third party vendor and is delayed by at least 20 minutes unless otherwise noted. The Third Party Information does not represent BMO InvestorLine’s views, and is not intended to provide investment, tax, accounting or legal advice nor does it constitute a solicitation of any offer to buy or sell any securities. We cannot guarantee the accuracy of the information provided. BMO InvestorLine and its Information Providers shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. The Third Party Information is the intellectual property of the contributing Information Provider, the use of which is subject to applicable laws and/or restrictions related to copyright, trademark, re-publication, and redistribution. For further information, please refer to our legal section.
Close
Print
AURORA CANNABIS INC (CA: ACB)
Real-time
Last: 10.80 Change: 0.00 Volume: 0 Last Trade: 03/05
News Story
Stock Market Press Highlights Metatron, Inc. Targets Explosive Market Growth with Launch of CBD Online Store with Famous Smoke Shop and Gifts; Other Companies Discussed Include Tilray, Inc., Cronos Group, Inc. and Aurora Cannabis Inc
06 Mar 2019 08:15 ET
ACCESSWIRE
NEW YORK, NY / ACCESSWIRE / March 6, 2019 / Stock Market Press (SMP) focuses on CBD market expansion after 2018 Farm Bill became law earlier this year. Companies covered in this spotlight include Tilray, Inc. (NASDAQ: TLRY), Aurora Cannabis Inc. (NYSE: ACB), Cronos Group, Inc. and Metatron, Inc. (OTC PINK: MRNJ).
Image: https://www.accesswire.com/users/newswire/images/538090/stockmarketpressmarch6.png
A massive boost to the US Hemp industry just occurred as sweeping change is enacted thanks to the passage and signing of the 2018 Farm Bill by President Trump. As a result, it is now legal to cultivate Hemp in the USA. This has opened the doors to a significant boost in CBD store fronts, both brick and mortar, as well as online. The CBD market is expected to reach over $2B in the next year according to various analysts, with some looking at a 10 fold increase by 2022. Enter Metatron, Inc. (OTC: MRNJ) and Smoke Shop and Gifts' creation of a brick & mortar and online powerhouse.
Metatron, Inc. (OTC: MRNJ) just announced the opening of a "groundbreaking CBD Online Store with Smoke Shop and Gifts ('SSG')":
SSG Customer Service and Extreme Quality is their #1 Priority. SSG was founded in 2016 with the vision of providing the highest quality hemp flower and CBD for daily use. After a long journey and years of searching, they found the perfect Hemp farms that shared SSG's vision. Working closely with these farms, they were able to source high-grade CBD hemp flower that is legal, testing with less than the U.S. allowed .3% Delta 9 THC. - Metatron 3/6/19 PR
This Metatron, Inc. (OTC: MRNJ) announcement comes on the heels of Tilray, Inc. (NASDAQ:TLRY) announcing the acquisition of the world's largest hemp foods manufacturer - Manitoba Harvest. Including the 19% stake owned by Cronos. With sales to over 16,000 retail locations between the USA and Canada, Tilray, Inc. has positioned themselves well to take advantage of the exponential growth expected in the CBD retail market.
The CBD marketplace consists of medical and consumer products, a market that Aurora Cannabis Inc. (NYSE:ACB) knows well. Aurora Cannabis Inc secures a keystone of their growth plan with the completion of the acquisition of all the issued and outstanding shares of Whistler Medical Marijuana. Organic certified products, a Whistler specialty, will help Aurora Cannabis, Inc. expand their product reach to Europe and the rest of the world.
From large cap to small cap, companies are taking advantage of the new Hemp legalization by expanding across the USA. Metatron, Inc. (OTC: MRNJ) and Smoke Shop and Gifts are taking the 'bull by its horns' and launching nationwide with the new mobile CBD storefront.
New customers of Smoke Shop and Gifts can receive 10% off their first order by using the code "SSG10" upon checkout.
Stock Market Press is a financial news company that delivers up to date stock news, introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network.
Contact:
Stock Market Press110 Wall St.New York, NY 10005info@stockmarketpress.comhttps://twitter.com/PressStock
Safe Harbor Statement:
Statements in this news release may be ''forward-looking statements.'' Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release and Stock Market Press undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.
See Stock Market Press disclaimer: http://stockmarketpress.com/disclaimer/
Update on Stock To Watch: Aurora Cannabis on Construction of Aurora Polaris; But Still Down 4% in US Pre-Mkt After Q2 Result
12 Feb 2019 07:11 ET
07:11 AM EST, 02/12/2019 (MT Newswires) -- Aurora Cannabis (ACB.TO) was at last look still down 4% in US pre-market (adding to the near 5% lost on the NYSE yesterday), largely on the back of its overnight Q2 earnings report. But in other news, ACB has announced that its construction of a 300,000 square foot expansion at the Edmonton International Airport is "progressing well." According to ACB's statement, the new facility, named Aurora Polaris, is intended to serve as Aurora's centre of excellence for the industrial-scale production of higher margin, value added products, such as edibles which Health Canada regulations propose to permit from October 2019 onwards. It said Aurora Polaris will allow for enhanced capabilities for the company's logistics and warehousing needs required to serve ever increasing global requirements. The facility is designed to include additional research and development space. It added construction of the facility is anticipated to be completed in late 2019. Polaris is immediately adjacent to Aurora's Sky facility.
Overnight, ACB reported Q2 net revenue of $54.2 million, up 83% sequentially, and up 363% compared to the same period in 2018, driven by Aurora's strong performance in the launch of the Canadian consumer market with sales of $21.6 million, and the company's continued strength in the Canadian and international medical markets with sales of $26.0 million, up 8% in revenue and 23% in volume sold. The sales figure was at the high end of the range that Aurora forecast. It beat the $51.84 million average of two analyst estimates, according to IBES data from Refinitiv, Reuters noted.
Among other highlights: Loss in earnings attributable to common shareholders was near $235 million compared to a modest profit of near $7 million a year ago, not helped by noncash losses on investments; Average selling prices were impacted by the introduction of excise taxes across all Canadian sales channels on October 17, 2018, as well as lower wholesale pricing realized in the Canadian consumer market. Going forward, Aurora intends to continue prioritizing medical patients in Canada and globally where margins continue to exceed those achieved on the wholesale consumer market.
Meanwhile, Q2 2019 kilograms produced and kilograms sold of 7,822 and 6,999 were up 57% and 162%, respectively, driven by continued and significant scale-up of Aurora's cultivation operations and strong demand across all the company's markets. According to Barron's, the produced 7.8 million kilograms in the quarter compared to an expected 6.6 million.
Price: 9.50, Change: -0.45, Percent Change: -4.52
Close
Print
AURORA CANNABIS INC (CA: ACB)
Real-time
Last: 10.28 Change: 0.30 Volume: 7,546,515 Last Trade: 10:06
News Story
Global Industrial Hemp Production Picking up Steam Quickly
07 Feb 2019 08:30 ET
CNW Group
The seemingly never ending rise of revenue projections for hemp products goes hand-in-hand with the consumer markets growing acceptance of the products inherent attributes. Research reports find that: "The global industrial hemp market size was estimated at USD 3.9 billion in 2017, expanding at a CAGR of 14.0% over the forecast period. Growing demand for hemp-based food products including cooking oil, dairy alternatives, flour, and salad dressings is expected to drive market growth. In addition, rising demand for bakery products such as bread and cookies is expected to drive the market. The report continues:" The industry is witnessing growth on account of increasing consumer awareness pertaining to benefits associated with hemp products. The product is a rich source of omega-3 and omega-6, amino acids, and proteins. These nutrients aid in insulin balance, cardiac function, mood stability, and skin and joint health, which is expected to complement industry growth." Active companies in the cannabis industry this week includes: Future Farm Technologies Inc. (CSE: FFT) (OTCQB: FFRMF), Green Growth Brands Inc. (CSE: GGB) (OTC: GGBXF), Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB), The Green Organic Dutchman Holdings Ltd. (OTC: TGODF) (TSX-V: TGOD), OrganiGram Holdings Inc. (OTC: OGRMF) (TSX-V: OGI).The researchers added: "The global industrial hemp market size is expected to reach USD 10.6 billion by 2025, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 14.0% during the forecast period. Rising demand for oil in food and beverages owing to growing awareness regarding dietary advantages of hempseed and oil is expected to propel demand.
Future Farm Technologies Inc. (CSE: FFT) (OTCQB: FFRMF) BREAKING NEWS: As it prepares to begin selling its inventory of Cherry Wine hemp seeds for CBD-producing hemp, Future Farm Technologies is pleased to announce that its Maine subsidiary, Future Farm Maine, will soon be offering for sale its inventory of Cherry Wine hemp seeds for CBD-producing hemp.Click here to view Future Farm Maine's harvest video.In 2018, Future Farm hand-selected the Cherry Wine seeds to be offered for sale from more than 50,000 hemp plants to allow purchasers of those seeds to maximize the success of their harvests of hemp. The Company expects the sales of those seeds during calendar 2019 to have a significant positive impact on both its revenue and bottom line, as compared to the current fiscal year, because the costs associated with producing those seeds are expected to be significantly less than the revenue that the sale of the seeds will generate. Future Farm is in the process of creating a website to support its seed sales effort, but in the meantime inquiries can be sent to sales@futurefarmtech.com.As these efforts advance in Maine, the Company's lab in Belfast is up and running, collecting data to enable the Company to refine procedures as needed and begin sales of CBD distillate in the near future. In March, Zachary Lapan, Manager of the Company's Maine cultivation and processing operations, along with George Groccia, Future Farm's organizational and operational manager, will share their experience working on the Maine farm as speakers at the 2019 New England Cannabis Convention in Boston. Read this full announcement and more news for Future Farm Technologies at: https://www.financialnewsmedia.com/news-fft/ Additional cannabis industry related developments from around the markets: Green Growth Brands Inc. (CSE: GGB.CN) (OTCQB: GGBXF) recently the company announced that it executed an arm's length definitive agreement to acquire control of ZLJT LLC & Arizona Natural Pain Solutions Inc, collectively referred to as "Desert Rose". Desert Rose holds a license for a vertically-integrated operation in Arizona , including retail, cultivation & infusion (kitchen). As consideration for the membership interests, GGB will pay an aggregate purchase price of USD$12,350,000 (CAN$16,292,120) in cash.
"We were very impressed with the quality of the operations held by Arizona Natural Pain Solutions," said Green Growth Brands CEO Peter Horvath . "At Desert Rose, the team is dedicated to providing their customers with medical marijuana products that are pure, safe, and efficient while striving to keep their costs as affordable as possible. This strategy fits perfectly with our plans to grow the world's premier cannabis retailing business."
Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) announced today that its extraction technology partner, Radient Technologies ("Radient") (TSX-V: RTI; OTCQX: RDDTF), has received its Standard Processing License from Health Canada. In 2016, Aurora identified Radient's proprietary extraction technology (MAPTM) as potentially disruptive for the cannabis industry due to its ability to achieve much higher throughputs than is possible with existing benchmark technologies, as well as its efficiency and ability to preserve the full spectrum of cannabinoids and terpenes found in the source material. These aspects provide key competitive advantages in the development and large-scale production of high-quality derivative products.
The Green Organic Dutchman Holdings Ltd. (OTCQX: TGODF) (TSX-V: TGOD) yesterday the company announce that, further to its news release of January 24, 2019 announcing the record date for the distribution (the "Distribution") of unit purchase warrants ("SpinCo Unit Warrants") of TGOD Acquisition Corp. ("SpinCo") under its previously announced plan of arrangement with SpinCo (the "Arrangement"), TGOD has now mailed an election form (the "Election Form") to all registered TGOD shareholders of record as of January 31, 2019 (the "Distribution Record Date") who have an address of record outside the United States . All non-U.S. registered TGOD shareholders of record as of the Distribution Record Date who wish to receive the SpinCo Unit Warrants they are entitled to under arrangement must complete the Election Form and deliver it to Computershare Investor Services Inc. as the tabulation agent (the "Tabulation Agent") by 4:00 p.m. ( Toronto time) on February 22, 2019 (the "Election Deadline") or they will lose their right to receive any SpinCo Unit Warrants.
OrganiGram Holdings Inc. (OTCQX: OGRMF) (TSX-V: OGI.V) recently announced that it has reached - and already surpassed - the production of one million cannabis pre-rolls since the legalization of adult use recreational cannabis in October 2018. The Company credits the automation of its processes along with surging consumer demand for the success of its large-scale production. "At Organigram, we are proud to be among a select group of licensed producers who have been able to rise to the challenge of large-scale pre-roll production," says Greg Engel, CEO, Organigram. "Our operations team has done an amazing job introducing automation to important parts of our process, building our overall capacity while retaining our focus on product quality."
DISCLAIMER: FN Media Group LLC (FNM), which owns and operates FinancialNewsMedia.com and MarketNewsUpdates.com (FNM) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with any company mentioned herein. FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNM is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNM has been compensated twenty six hundred dollars for news coverage of the current press release issued above by Future Farm Technologies Inc. by the company. FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.
Contact Information:Media Contact email: editor@financialnewsmedia.com+1(561)325-8757
View original content:http://www.prnewswire.com/news-releases/global-industrial-hemp-production-picking-up-steam-quickly-300791468.html
SOURCE FinancialNewsMedia.com
View original content: http://www.newswire.ca/en/releases/archive/February2019/07/c8837.html
SOURCE: FinancialNewsMedia.com
Copyright (C) 2019 CNW Group. All rights reserved.
Chart not available
Important Legal Notice: All market data is provided by a third party vendor and is delayed by at least 20 minutes unless otherwise noted. The Third Party Information does not represent BMO InvestorLine’s views, and is not intended to provide investment, tax, accounting or legal advice nor does it constitute a solicitation of any offer to buy or sell any securities. We cannot guarantee the accuracy of the information provided. BMO InvestorLine and its Information Providers shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. The Third Party Information is the intellectual property of the contributing Information Provider, the use of which is subject to applicable laws and/or restrictions related to copyright, trademark, re-publication, and redistribution. For further information, please refer to our legal section.
Need Help?
what the fuck is going with this stock
this same happened with CGC from 44.50 down to 41.00
Can someone tell me why this shit does not go to the top like CGC and TLRY
Is ACB worth anything? It looks like it is one scam.
ACB on TSX today down to $6.48 cad.This is something terrible.
The Future of CBD for Pain Treatment and Sports Medicine: Orion Nutraceuticals Inc. (CSE: ORI), Aurora Cannabis Inc., CannTrust Holdings Inc., Kalytera Therapeutics
20 Nov 2018 09:00 ET
GlobeNewswire
Investorideas.com, a leading investor news resource for cannabis stocks releases a snapshot looking at CBD and its future role as a pain treatment in healthcare, and how it is being advocated and embraced by professional athletes.
The World Anti-Doping Agency (WADA) officially removed cannabidiol (CBD) from its Prohibited Substances List effective January 1, 2018 and that has opened up a lot of opportunity for athletes looking for more natural pain treatment solutions and companies in the space.
In June of this year, The BIG3 basketball league announced they will allow players to use cannabidiol (CBD) as a pain treatment and for recovery. "The BIG3 is uniquely positioned in professional sports as a player-powered league that looks at our players as partners not property," BIG3 co-founder and co-CEO Jeff Kwatinetz said in a statement. "As a testament to our relationship with our players, we listened to their feedback on CBD, as well as feedback from professionals in the regulatory and CBD industry, and decided to take this major step to support their health."
NFL Players are some of the biggest advocates of the use of CBD for pain and sports injuries and as a Washington Post article explains, "No professional sport has so many outspoken proponents of marijuana's medicinal qualities, but then again, no sport is as closely associated with pain and injury."
Looking at capitalizing on the CBD market opportunity, cannabis life science company Orion Nutraceuticals Inc. (CSE: ORI), just announce today it is entering the sports medicine CBD market with the addition of Shannon Ford-Smith, sports healthcare and CBD product expert to its advisory board.
From the news: Shannon Ford-Smith has a uniquely diverse background that includes education, construction, consumer goods as well as experience building and leading companies in the sports healthcare sector. She has over a decade of experience building, leading and establishing business direction.
Continued: Throughout her career she has developed deep market insight into the healthcare field. Her recent executive role at Floydʼs of Leadville as Director of Business Development includes the development of Aeliza (a medical grade CBD product line) and oversight of the Companyʼs expansion and growth into the Canadian market, hiring and leading the execution of a common vision of success while mitigating risk. She spearheaded development of the Aeliza line and personally oversaw every detail, from product development and formulation, manufacturing, business development, marketing, strategy, as well as bridging the gap between the medical world and cannabis.
Continued: "We are extremely pleased to add Shannon Ford-Smith to Orion Nutraceutical's advisory board", said Jonathan Fiteni, CEO of Orion. "Her impressive resume includes a strong background in both healthcare and business development. Shannon's experience in creating the CBD product line Aeliza will prove instrumental in the creation of Orion's own sports medicine CBD product lines."
Also looking at CBD for pain treatment, Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) and McGill University announced in August, the launch of an international collaborative medical research project that will comprehensively examine the therapeutic impact and human health outcomes of cannabidiol (CBD) oil as a therapy for chronic pain and related anxiety and depression.
From the news: "Based on our extensive experience with more than 60,000 registered Canadian patients, we believe CBD to be one of the most impactful medical compounds to become legally available to people in need of non-addictive therapies to treat pain," stated Terry Booth, CEO. "Our support for and involvement with this project underlines Aurora's leadership in the medical cannabis space, as well as our long-term commitment to a science-based approach to deepen understanding of this amazing substance."
Taking a similar path and partnering with a major University, CannTrust Holdings Inc. (TSX: TRST), partnered with McMaster University on medicinal cannabis research for chronic pain and for designing more effective, safer treatment protocols in public health policies.
The race is on for companies in the sector and new advancements are being made. In late September, Kalytera Therapeutics, Inc. (TSX V: KALY) (OTCQB: KALTF) announced a major step forward in its program to develop the first cannabinoid-derived pain treatment targeting activation of alpha3 glycine receptors.
"When activated, the alpha3 glycine receptor strongly blocks pain signals from being sent to the brain. Kalytera, and its research partner, Beetlebung Pharma Ltd. ("BPL"), have carried out a medicinal chemistry program to identify a novel analogue of cannabidiol ("CBD") that will block such pain signals via the activation of the alpha3 glycine receptor channel in the spinal cord. To date, no company has introduced into the market an agent specifically targeting this receptor."
As far as CBD's role in sports, it is really just the beginning. According to an article in SportsNet, "Former star NFL running back Ricky Williams thinks cannabis legalization in Canada is "a huge step forward" towards professional sports leagues like the NFL softening their stances on athletes using marijuana therapeutically."
For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks
About Investorideas.com - News that Inspires Big Investing Ideas
https://www.investorideas.com/About/
Follow us on our Cannabis Social Media
https://www.facebook.com/Investorideaspotcasts/
https://twitter.com/MJInvestorIdeas
https://www.instagram.com/potcasts_investorideas/
This news is published on the Investorideas.com Newswire - News that Inspires big ideas Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: this news article featuring ORI is a paid for news release on Investorideas.com - third party, Learn more about costs and our services https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulation
High Tide Subsidiary RGR Canada Receives Record Accessories Purchase Order from Aurora Cannabis
13 Nov 2018 08:45 ET
CNW Group
High Tide Inc. ("High Tide" or the "Company") today announced that its wholly-owned subsidiary, RGR Canada Inc. ("RGR Canada") recently received from Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1C4WM) ("Aurora") its largest ever wholesale purchase order for smoking accessories (the "Order"). This Order from Aurora is for a customized line of smoking accessories across multiple categories including bubblers, grinders, hand pipes, hemp wicks, sherlocks, vaporizers and water pipes. High Tide has commenced the process of converting its proprietary designs into manufactured products for its new client.
Established in late 2010, RGR Canada currently manufactures over 3,000 different smoking accessories and lifestyle products and also distributes over 1,000 other SKUs from around the world. "This record purchase order from Aurora is a major milestone for High Tide, a validation of our designs and the beginning of what we expect will be a very important business relationship for our Company," said Raj Grover, President & Chief Executive Officer of High Tide. "There is no better company than Aurora to have as our largest customer to date, and we look forward to capitalizing on the increased recognition that this order brings to High Tide's product offering to attract and drive additional growth." Terry Booth, Chief Executive Officer of Aurora, added, "High Tide is a unique player with a very strong offering of high-quality accessories in the Canadian marketplace that is helping Aurora to differentiate itself even further through this exciting purchase of branded accessories."
Since Bill C-45 was signed into law, RGR Canada has been accepting orders and receiving inquiries for smoking accessories and lifestyle products from retailers from around the world and the Company is currently in discussions with other large cannabis companies to create white-label products. High Tide's other wholesale accessories subsidiary, Famous Brandz, also recently reported a significant achievement when it entered into an agreement to supply the Ontario Cannabis Store with a variety of smoking accessories from its "Famous X" line of products. High Tide's retail cannabis subsidiaries, Canna Cabana and KushBar, currently have 28 development permits to open stores across Alberta, with the Company's first Canna Cabana store opened in Calgary on October 27, 2018. As a result, High Tide is well positioned to continue serving a rapidly growing number of customers on both a wholesale and retail basis.
About High Tide Inc.
High Tide is a privately-held, Alberta-based, retail-focused cannabis corporation. It is among the most vertically-integrated companies in the Canadian cannabis market, with portfolio subsidiaries including RGR Canada Inc., Smoker's Corner Ltd., Famous Brandz Inc., Canna Cabana Inc. and the majority of KushBar Inc. High Tide's strategy as a parent company is to extend and strengthen its retail-focused integrated value chain, while providing a complete customer experience and maximizing shareholder value.
Representing the core of High Tide's business, RGR Canada Inc. is a high-quality and innovative designer, manufacturer and distributor of cannabis accessories. Founded in 2009 and approved by the Canadian Franchise Association, Smoker's Corner Ltd. is Canada's largest counter-culture chain with 19 current locations. Famous Brandz Inc. is a dominant manufacturer of licensed lifestyle accessories, through partnerships with celebrities and entertainment companies including Snoop Dogg and Paramount Pictures. Famous Brandz' products are sold to wholesalers and retailers around the world. With the deregulation of recreational cannabis for adult use across Canada, Canna Cabana Inc. is positioned to become a sizeable retail brand through a modern concept with a sophisticated yet playful customer experience, while KushBar Inc. is a retail concept that will also be focused on the valued Canadian cannabis consumer.
For more information about High Tide Inc., visit www.hightideinc.ca
About Aurora
Headquartered in Edmonton, Alberta, Canada with funded capacity in excess of 500,000 kg per annum and sales and operations in 19 countries across five continents, Aurora is one of the world's largest and leading cannabis companies. Aurora is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, high value-add product development, home cultivation, wholesale and retail distribution.
Highly differentiated from its peers, Aurora has established a uniquely advanced, consistent and efficient production strategy, based on purpose-built facilities that integrate leading-edge technologies across all processes, defined by extensive automation and customization, resulting in the massive scale production of high quality product at low cost. Intended to be replicable and scalable globally, our production facilities are designed to produce cannabis of significant scale, with high quality, industry-leading yields, and low per gram production costs. Each of Aurora's facilities is built to meet EU GMP standards, and its first production facility, the recently acquired MedReleaf Markham facility, and its wholly owned European medical cannabis distributor Aurora Deutschland, have achieved this level of certification.
In addition to Aurora's rapid organic growth and strong execution on strategic M&A, which to date includes 15 wholly owned subsidiary companies - MedReleaf, CanvasRX, Peloton Pharmaceutical, Aurora Deutschland, H2 Biopharma, Urban Cultivator, BC Northern Lights, Larssen Greenhouses, CanniMed Therapeutics, Anandia Labs, HotHouse Consulting, MED Colombia, Agropro, Borela, and the pending acquisition of ICC - Aurora is distinguished by its reputation as a partner and employer of choice in the global cannabis sector, having invested in and established strategic partnerships with a range of leading innovators, including: Radient Technologies Inc. (TSXV: RTI), Hempco Food and Fiber Inc. (TSXV: HEMP), Cann Group Ltd. (ASX: CAN), Micron Waste Technologies Inc. (CSE: MWM), Choom Holdings Inc. (CSE: CHOO), Capcium Inc. (private), Evio Beauty Group (private), Wagner Dimas (private), CTT Pharmaceuticals (OTCC: CTTH), and Alcanna Inc. (TSX: CLIQ).
Aurora's Common Shares trade on the TSX and NYSE under the symbol "ACB" and are a constituent of the S&P/TSX Composite Index.
For more information about Aurora, please visit investor.auroramj.com
Forward-Looking Information
Certain statements in this news release are forward-looking information or forward-looking statements. Such information and statements, referred to herein as "forward-looking statements" are made as of the date of this news release or as of the date of the effective date of information described in this news release, as applicable. Forward-looking statements relate to future events or future performance and reflect current estimates, predictions, expectations or beliefs regarding future events. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (generally, forward-looking statements can be identified by use of words such as "outlook", "expects", "intend", "forecasts", "anticipates", "plans", "projects", "estimates", "envisages, "assumes", "needs", "strategy", "goals", "objectives", or variations thereof, or stating that certain actions, events or results "may", "can", "could", "would", "might", or "will" be taken, occur or be achieved, or the negative of any of these terms or similar expressions, and other similar terminology) are not statements of historical fact and may be forward-looking statements.
Such forward-looking statements are based on assumptions that may prove to be incorrect, including but not limited to the ability of High Tide to execute on its business plan and that High Tide will receive one or multiple licenses from Alberta Gaming, Liquor & Cannabis, British Columbia's Liquor Distribution Branch or the Saskatchewan Liquor and Gaming Authority permitting it to carry on its Canna Cabana Inc. and KushBar Inc. businesses. High Tide considers these assumptions to be reasonable in the circumstances. However, there can be no assurance that any one or more of the government, industry, market, operational or financial targets as set out herein will be achieved. Inherent in the forward-looking statements are known and unknown risks, uncertainties and other factors that could cause actual results, performance or achievements, or industry results, to differ materially from any results, performance or achievements expressed or implied by such forward-looking statements.
The forward-looking statements contained herein are current as of the date of this news release. Except as required by law, High Tide does not have any obligation to advise any person if it becomes aware of any inaccuracy in or omission from any forward-looking statement, nor does it intend, or assume any obligation, to update or revise these forward-looking statements to reflect new events or circumstances. Any and all forward-looking statements included in this news release are expressly qualified by this cautionary statement, and except as otherwise indicated, are made as of the date of this news release.
SOURCE High Tide Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/November2018/13/c1588.html
SOURCE: High Tide Inc.
please contact Nick Kuzyk, Chief Strategy Officer & SVP Capital Markets at High Tide
Inc.; Tel: (403) 265-4207; Email: Nick@HighTideInc.ca; Web: www.HighTideInc.ca.
Copyright (C) 2018 CNW Group. All rights reserved.
MT Newswires Click for Restrictions.
Any comments on conference call ?
this is f****g ridiculous this stock is crap
UPDATE -- Cannabis Beverage Market Snapshot; American Premium Water (OTC: HIPH), Aurora Cannabis, Canopy Growth Corporation, The Hydropothecary Corporation
26 Oct 2018 10:30 ET
GlobeNewswire
Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks releases a sector snapshot with a focus on CBD and THC beverage deals brewing as the legal cannabis market in Canada just opened up new opportunities. Companies mentioned: American Premium Water Corporation (OTC: HIPH), Aurora Cannabis Inc. (TSX: ACB.TO), (NYSE: ACB), Canopy Growth Corporation (TSX: WEED.TO), The Hydropothecary Corporation (TSX: HEXO.TO).
From announced deals of 'Constellation Brands to Invest $5 Billion CAD [$4 Billion USD] in Canopy Growth to Establish Transformative Global Position and Alignment', to speculative deals like the Aurora Cannabis Inc. (TSX: ACB.TO) (NYSE: ACB) Coca-Cola deal, the amount of money at stake is staggering.
According to the news from Ontario based Canopy Growth Corporation (TSX: WEED.TO) (NYSE: CGC), commenting on the Constellation Brands deal, "This investment, the largest to date in the cannabis space, will provide funds which Canopy Growth will deploy to strategically build and/or acquire key assets needed to establish global scale in the nearly 30 countries pursuing a federally permissible medical cannabis program, while also rapidly laying the global foundation needed for new recreational cannabis markets. Canopy Growth's Canadian platform does not require additional cannabis cultivation assets, and management views other jurisdictions, including the United States, as strategic priorities requiring significant capital."
In a recent Time.com article looking at the potential Coca-Cola /Aurora Cannabis Inc. (TSX: ACB.TO) (NYSE: ACB) deal, it's noted, "Coke's possible foray into the marijuana sector comes as beverage makers are trying to add cannabis as a trendy ingredient while their traditional businesses slow." The article also includes a statement from Coca-Cola; '"We are closely watching the growth of non-psychoactive CBD as an ingredient in functional wellness beverages around the world," Coca-Cola spokesman Kent Landers said in an emailed statement to Bloomberg News.'
rora Cannabis Makes Application to List on the NYSE; Follows Likes of Canopy Growth and Cronos Group
09 Oct 2018 07:06 ET
07:06 AM EDT, 10/09/2018 (MT Newswires) -- Aurora Cannabis Inc. (ACB.TO) announced Tuesday that the company has filed an application to list its common shares on the New York Stock Exchange. It will follow the likes of rivals Canopy Growth (WEED.TO, CGC) and Cronos Group (CRON.TO, CRON) in so doing.
In a statement ACB said listing of its common shares on the NYSE remains subject to the approval of the NYSE and the satisfaction of all applicable listing and regulatory requirements. Aurora anticipates that, subject to receipt of all required approvals, trading in its common shares on the NYSE will commence before the end of October 2018. In advance of the intended listing, the company has filed a Form 40-F Registration Statement with the United States Securities and Exchange Commission.
Aurora's shares will trade on the NYSE under ticker symbol 'ACB', the same symbol the company's common shares currently, and will continue to, trade under on the Toronto Stock Exchange. Aurora will also continue to trade on the OTCQX under the ticker symbol 'ACBFF' until completion of the NYSE listing. Upon receipt of all required approvals and completion of the formal listing process, the company said it will publicly announce its first trading date on the NYSE. Aurora, furthermore, intends to voluntarily delist its shares from the OTCQX at such time.
"Through our NYSE listing, Aurora joins an established group of mature global brands with improved access and exposure to an engaged international institutional investor audience," said Terry Booth, CEO of Aurora. "Aurora's high-paced execution has made it one of the world's leading cannabis companies. We have grown from being a licensed producer with a single facility, to a horizontality differentiated and vertically integrated global organization with a funded production capacity in excess of 500,000 kg a year, sales and operations on five continents, and a team of more than 1,500 employees."
Booth added: "Our purpose-built, indoor grow facilities, designed to meet the stringent requirements for furnishing product to international markets, have made Aurora the largest supplier of medical cannabis in Europe. We are also well-prepared for the launch of the domestic adult consumer use market in Canada with a portfolio of strong consumer brands and coast-to-coast provincial supply arrangements covering 98% of the Canadian population."
Price: 12.81, Change: +0.65, Percent Change: +5.35
MT Newswires Click for Restrictions.
Aurora Cannabis Partners with Elevate to Create Cannabis Education Tracks Featuring Industry Leaders
25 Sep 2018 10:22 ET
CNW Group
Elevate Health and Elevate Cannabis tracks explore how science, finance and entrepreneurship will help shape the future of the global cannabis industry
One of Canada's leading licensed producers, Aurora Cannabis, has partnered with Elevate, Canada's Tech Week, to present a stand-out roster of panel discussions and interactive sessions with innovators and pioneers in the cannabis industry.
As a gold partner of Elevate, Canada's largest tech and innovation festival, Aurora has been instrumental in shaping the Elevate Cannabis and Elevate Health tracks that will feature leading experts in research, medicine, finance and entrepreneurship in the cannabis industry.
"We are thrilled to partner with Elevate this year. This conference is about showcasing Canada as a leader in technology as well as demonstrating a diverse and inclusive society. This is precisely what Aurora stands for - innovation, community, culture," says Paula Whitmore, Director, Partnerships and Events, Aurora. "The line-up of speakers and topics demonstrates our desire to work with different industries to develop innovative solutions and products in the recreational and medical environments."
Aurora and Elevate are pleased to announce a diverse group of thought leaders throughout the Elevate Cannabis and Elevate Health tracks, including:
-- Dr. Jonathan Page: Co-founder of Anandia Laboratories Inc., a
pioneer in the cannabis field who co-led the Canadian team that
first sequenced the cannabis genome. His work has helped
discover the biochemical pathway of the major cannabinoids.
-- Kelly Narine: Vice-President of Research, Aurora is leading
meaningful, robust research and clinical studies to generate
more evidence for the medical uses of cannabis and looking at
real-world outcomes globally.
-- Tarren Wolfe: Co-founder of BC Northern Lights and Urban
Cultivator, leaders in the commercial and residential
hydroponic industry that make growing sustainable, organic
cannabis, herbs and vegetables accessible to all.
-- Brandi Leifso: A 28-year old powerhouse who launched a socially
conscious brand of green beauty products with a mission to
break stigmas. In collaboration with Aurora, she'll be
launching a line of CBD-infused skincare.
Elevate Cannabis and Elevate Health are taking place at The Carlu, 444 Yonge St, 7(th) Floor, Toronto, on September 26, 2018. Elevate Cannabis opens at 8.30 a.m. and Elevate Health opens at 9 a.m.
About ElevateFor information about the Elevate, Canada's Tech week visit www.elevatetechfest.com.
About AuroraAurora Cannabis is a Canadian company that's redefining the thriving cannabis space. As one of the world's largest federally licensed, medical cannabis companies, Aurora is committed to providing its patients with the highest standard of product quality, customer service and affordable pricing, while removing barriers to access. A progressive leader, using innovative technologies and state-of-the-art facilities, the company cultivates and produces exceptional, high quality, safe medical cannabis available on the market. Its growing constellation of subsidiaries and strategic partners provides global reach, product choice and first-class delivery. Find out how Aurora is helping shape the future of cannabis at www.auroramj.com.
@Aurora_MMJ | Facebook: @aurorammj | Instagram: aurora_mmj | Hashtag: #auroraeverywhere
SOURCE Aurora Cannabis Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/September2018/25/c6530.html
SOURCE: Aurora Cannabis Inc.
Media Contacts: Aurora Cannabis, media@auroramj.com; Julie McCarthy, 416.788.8515,
jmccarthy@blueskycommunications.com; Zulfikar Fahd, 647-354-0575,
zfahd@blueskycommunications.com
Copyright (C) 2018 CNW Group. All rights reserved.
MT Newswires Click for Restrictions.
Cannabis and Biotech Stocks Making Investors Bank
20 Sep 2018 10:31 ET
ACCESSWIRE
HENDERSON, NV / ACCESSWIRE / September 20, 2018 / Cannabis and Biotech companies have been receiving increased attention from the street as of late. One particular company that has caught significant attention from the street is none other than PPCB (Propanc Biopharma, Inc.).
Propanc Biopharma, Inc. (PPCB) is a clinical stage biopharmaceutical company focusing on development of new and proprietary treatments for cancer patients suffering from solid tumors, such as pancreatic, ovarian and colorectal cancers. PPCB's lead product PRP was granted FDA Orphan Drug Designation status for the treatment of pancreatic cancer. This qualifies the Company for seven-year FDA-administered market Orphan Drug Exclusivity (ODE), tax credits of up to 50% of R&D costs, potential for R&D grants, waived FDA fees, protocol assistance and possible clinical trial tax incentives if conducted in the U.S. PPCB has some very exciting events on the horizon.
Biotechs and cannabis companies to watch include: Propanc Biopharma, Inc. (PPCB), Neptune Technologies & Bioresources, Inc. (NASDAQ: NEPT), Aurora Cannabis, Inc. (OTCQX: ACBFF), Cronos Group, Inc. (CRON), and The Green Organic Dutchman Holdings, Ltd. (OTCQX: TGODF).
Propanc Biopharma, Inc. (PPCB)
Market Cap: $7.68M Share Price: $0.062
PPCB's accomplishments are being noticed, they just announced that the Company received a positive reception after presenting at the prestigious 25th Annual NewsMakers in the Biotech Industry Conference on September 7th, at the Millennium Broadway Hotel and Conference Center in New York. Management thanked their gracious hosts at BioCentury for the opportunity to present at the prestigious conference, where only 45 companies were handpicked to present their stories to institutional investors in the biotech sector.
Neptune Technologies & Bioresources, Inc. (NEPT)
Market Cap: $14.43B Share Price: $154.98
Neptune Technologies & Bioressources Inc. recently appointed Ms. Helène F. Fortin to its Board of Directors. Helène F. Fortin FCPA, FCA, ICD.D-IAS.A has been practicing public accounting for more than 30 years. A member of CPA Quebec, she lectured in Accounting and Auditing during more than 20 years at many universities in both the undergraduate and graduate levels.
Aurora Cannabis (ACBFF)
Market Cap: $8.14B Share Price: $8.51
Aurora Cannabis Inc. (ACBFF) announced it, and its wholly-owned subsidiary MedReleaf, have entered into additional supply arrangements with a number of provinces across Canada to supply a broad range of dried flower and higher margin products, such as pre-rolls, oils and capsules. In addition to supplying adult-consumer use markets in British Columbia, Alberta, Ontario, Quebec and Nova Scotia, the Company is pleased to advise of arrangements with Yukon, Manitoba, Prince Edward Island and Newfoundland and Labrador. The Aurora and MedReleaf brands are expected to have a strong presence across Canada, positioning the Company well for rapid growth in the upcoming adult use market.
Cronos Group, Inc. (CRON)
Market Cap: $2.04B Share Price: $11.56
Earlier this month Cronos announced a partnership with Ginkgo Bioworks. The landmark partnership is to produce cultured cannabinoids. Ginkgo Bioworks, using its platform technology for organism design and development, will complement Cronos Group's technologies for producing a full spectrum of cannabinoids. Cronos Group has agreed to issue a specific number of common shares in tranches subject to Ginkgo's achievement of certain production milestones.
The Green Organic Dutchman Holdings, Ltd. (TGODF)
Market Cap: $1.682B Share Price: $6.68
On August 21st, the company announced it signed an agreement to acquire 100% of the issued and outstanding shares of privately-held HemPoland for $7.75M cash and 1,968,323 restricted TGODF shares currently worth $7.75M, which will be escrowed for a term of three years from closing.
Legal Disclaimer
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. ACR Communication, LLC, which owns Microcapspeculators.com, is not registered with Finra or any other financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. ACR Communication, LLC [and/or] Microcapspeculators.com does not have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. ACR Communication LLC, which owns Microcapspeculators.com, is compensated for its services in the form of cash-based compensation or in equity in the companies it writes about, or a combination of the two. ACR Communication, LLC has been compensated one thousand dollars cash for this article and eighty-six thousand four hundred dollars total by Regal Consulting. LLC, for news commentary articles for PPCB. PPCB and Regal Consulting, LLC were given an opportunity to edit information included in this article. This article is based solely on public information and the opinions of ACR Communication, LLC, which believes the news commentary to include accurate and complete information. ACR Communications, LLC. and the hiring party Regal Consulting, LLC. may buy or sell additional shares of PPCB in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.
For Full Legal Disclaimer Click Here.
Regal Consulting. LLC,For Full Legal Disclaimer Click Here.
Contact Information:
Company Name: Microcap Speculators
Contact Person: Media Manager
Email: info@microcapspecualtors.com
Phone: 1-702-720-6310
Country: United States
Website: http://microcapspeculators.com/
SOURCE: ACR Communication, LLC
https://www.accesswire.com/512297/Cannabis-and-Biotech-Stocks-Making-Investors-Bank
https://www.accesswire.com/img.ashx?id=512297
Copyright 2018 ACCESSWIRE
MT Newswires Click for Restrictions.
Companies Mentioned
Symbol Last Change Volume
ACB 12.25 1.38 56,510,135
Trade Now
as of Sep 20, 2018 16:38 ET
< Back to News Headlines
Market Chatter: Aurora Cannabis Targeting October For U.S. Stock Listing
20 Sep 2018 09:08 ET
09:08 AM EDT, 09/20/2018 (MT Newswires) -- Alberta-based marijuana producer Aurora Cannabis Inc. (ACB.TO) is looking at listing shares on a major United States stock exchange in October, according to one of its executives, the Financial Post has reported.
"We're targeting the month of October to establish a U.S. listing," said Cam Battley, Aurora's chief corporate officer, in an interview with the Financial Post on Tuesday.
Battley reportedly told the Post that such a move would continue to broaden the scope of Aurora's would-be investors, "including U.S. institutional investors, not all of whom are able to trade in OTC-listed securities," he said.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
Price: 10.87, Change: -0.15, Percent Change: -1.36
Aurora Cannabis Grows 9% as Distributes Australis Capital
19 Sep 2018 13:29 ET
01:29 PM EDT, 09/19/2018 (MT Newswires) -- Aurora Cannabis (ACB.TO) grew 9.5% to $12.07 apiece on Wednesday after saying it no longer has direct ownership in Australis after it completed its distribution of Australis shares and warrants.
Australis, now an independent entity, will begin trading on the CSE under the symbol "AUSA" effective today.
According to a statement, Aurora shareholders received one unit of Australis for every 34 Aurora shares outstanding as at August 24, 2018.
CEO Terry Booth said: "With the completion of this distribution we have delivered an immediate return of capital to Aurora shareholders while enabling the Australis team to proceed with their mandate to invest in U.S. cannabis assets with high growth potential."
Scott Dowty, CEO of Australis, said: "We will leverage the opportunities created by a fragmented U.S. cannabis market with limited access to growth capital. We have not wasted time and have already identified a number of strong assets within this market that we believe have high growth potential. With the completion of our over-subscribed private placement, we have the funds to start executing on these opportunities immediately and deliver growth."
Price: 12.08, Change: +1.06, Percent Change: +9.62
Aurora Cannabis Completes Distribution of Australis Capital
19 Sep 2018 07:30 ET
CNW Group
TSX: ACB
Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM), today announced that it has completed its previously announced distribution of Australis shares and warrants (the "Distribution"). The distribution was completed on September 19, 2018, and the Australis shares and warrants will commence trading on the CSE under the symbol "AUSA" effective at the market open today.
In accordance with the terms of the Distribution, eligible Aurora shareholders were paid one unit of Australis for every 34 Aurora shares outstanding as at August 24, 2018 (the "Record Date). Each unit consists of one common share and one share purchase warrant of Australis. Each warrant entitles the holder thereof to acquire one share at an exercise price of $0.25 per Australis share, on or prior to 4:00 p.m. (Eastern Time) on the date that is one year after the Distribution.
As described in further detail in the Final Prospectus, no units were issued to shareholders who are (or were deemed to be) non-residents of Canada. Rather, such units have been delivered to a custodian for sale in the open market following the Distribution, and the net cash proceeds will be delivered to non-resident shareholders, net of any withholding taxes.
Following the distribution, Aurora has no direct ownership interest in Australis, and the company is an independently operating entity. Aurora, however, does hold two warrants, allowing the Company to acquire an ownership interest at such time in the future (within 10 years) when holding investments in U.S. cannabis assets will become permissible.
"With the completion of this distribution we have delivered an immediate return of capital to Aurora shareholders while enabling the Australis team to proceed with their mandate to invest in U.S. cannabis assets with high growth potential," said Terry Booth, CEO of Aurora. "Australis' management, board of directors and investment committee are well positioned to leverage their collective knowledge and extensive experiences to rapidly execute on the tremendous opportunity ahead to generate substantial long-term shareholder value."
Scott Dowty, CEO of Australis, added, "We will leverage the opportunities created by a fragmented U.S. cannabis market with limited access to growth capital. We have not wasted time and have already identified a number of strong assets within this market that we believe have high growth potential. With the completion of our over-subscribed private placement, we have the funds to start executing on these opportunities immediately and deliver growth."
In accordance with the terms of the Distribution, eligible Aurora shareholders were paid one unit of Australis for every 34 Aurora shares outstanding as at August 24, 2018 (the "Record Date). Each unit consists of one common share and one share purchase warrant of Australis. Each warrant entitles the holder thereof to acquire one share at an exercise price of $0.25 per Australis share, on or prior to 4:00 p.m. (Eastern Time) on the date that is one year after the Distribution.
Aurora Cannabis Completes Distribution of Australis Capital
19 Sep 2018 07:30 ET
CNW Group
TSX: ACB
Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM), today announced that it has completed its previously announced distribution of Australis shares and warrants (the "Distribution"). The distribution was completed on September 19, 2018, and the Australis shares and warrants will commence trading on the CSE under the symbol "AUSA" effective at the market open today.
In accordance with the terms of the Distribution, eligible Aurora shareholders were paid one unit of Australis for every 34 Aurora shares outstanding as at August 24, 2018 (the "Record Date). Each unit consists of one common share and one share purchase warrant of Australis. Each warrant entitles the holder thereof to acquire one share at an exercise price of $0.25 per Australis share, on or prior to 4:00 p.m. (Eastern Time) on the date that is one year after the Distribution.
As described in further detail in the Final Prospectus, no units were issued to shareholders who are (or were deemed to be) non-residents of Canada. Rather, such units have been delivered to a custodian for sale in the open market following the Distribution, and the net cash proceeds will be delivered to non-resident shareholders, net of any withholding taxes.
Following the distribution, Aurora has no direct ownership interest in Australis, and the company is an independently operating entity. Aurora, however, does hold two warrants, allowing the Company to acquire an ownership interest at such time in the future (within 10 years) when holding investments in U.S. cannabis assets will become permissible.
"With the completion of this distribution we have delivered an immediate return of capital to Aurora shareholders while enabling the Australis team to proceed with their mandate to invest in U.S. cannabis assets with high growth potential," said Terry Booth, CEO of Aurora. "Australis' management, board of directors and investment committee are well positioned to leverage their collective knowledge and extensive experiences to rapidly execute on the tremendous opportunity ahead to generate substantial long-term shareholder value."
Scott Dowty, CEO of Australis, added, "We will leverage the opportunities created by a fragmented U.S. cannabis market with limited access to growth capital. We have not wasted time and have already identified a number of strong assets within this market that we believe have high growth potential. With the completion of our over-subscribed private placement, we have the funds to start executing on these opportunities immediately and deliver growth."
About Aurora
Headquartered in Edmonton, Alberta, Canada with funded capacity in excess of 500,000 kg per year and sales and operations in 18 countries across five continents, Aurora is one of the world's largest and leading cannabis companies. Aurora is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, high value-add product development, home cultivation, wholesale and retail distribution.
Highly differentiated from its peers, Aurora has established a uniquely advanced, consistent and efficient production strategy, based on purpose-built facilities that integrate leading-edge technologies across all processes, defined by extensive automation and customization, resulting in the massive scale production of high quality product at ultra-low costs. Intended to be replicable and scalable globally, these production facilities are designed to produce cannabis of significant scale, with high quality, industry-leading yields, and ultra-low per gram production costs. Each of Aurora's facilities is built to meet European Union (EU) GMP standards, and its first production facility, the recently acquired MedReleaf Markham facility, and its wholly owned European medical cannabis distributor Aurora Deutschland (formerly Pedanios), have achieved this level of certification.
In addition to the Company's rapid organic growth and strong execution on strategic M&A, which to date includes 15 companies - MedReleaf, CanvasRX, Peloton Pharmaceutical, Aurora Deutschland (formerly Pedanios), H2 Biopharma, Urban Cultivator, BC Northern Lights, Larssen Greenhouses, CanniMed Therapeutics, Anandia Labs, HotHouse Consulting, Agropro, Borela, and the pending acquisition of ICC Labs - Aurora is distinguished by its reputation as a partner of choice and employer of choice in the global cannabis sector, having invested in and established strategic partnerships with a range of leading innovators, including: The Green Organic Dutchman Holdings Ltd. (TSX: TGOD), Radient Technologies Inc. (TSXV: RTI), Hempco Food and Fiber Inc. (TSXV: HEMP), Cann Group Ltd. (ASX: CAN), Micron Waste Technologies Inc. (CSE: MWM), Choom Holdings Inc. (CSE: CHOO), Namaste Technologies Inc. (TSXV: N), Evio Beauty Group (private), Wagner Dimas (private), CTT Pharmaceuticals (OTCC: CTTH), and Alcanna Inc. (TSX: CLIQ).
Aurora's Common Shares trade on the TSX under the symbol "ACB", and are a constituent of the S&P/TSX Composite Index.
For more information about Aurora, please visit our investor website, investor.auroramj.com, Twitter, Facebook or Instagram
Terry Booth, CEOAurora Cannabis Inc.
About Australis
Australis Capital identifies and invests in the cannabis industry predominately in the United States, a highly regulated, fragmented, fast growing and evolving industry. Investments may include and are not limited to equity, debt or other securities of both public and private companies, financings in exchange for royalties or other distribution streams, and control stake acquisitions. Australis Capital adheres to stringent investment criteria and will focus on significant near and mid-term high-quality opportunities with strong return potentials while maintaining a steadfast commitment to governance and community. Australis Capital's Board, Management and Advisory Committee members have material experience with, and knowledge of, the cannabis space in the U.S., extensive backgrounds in highly regulated industries, adherence to stringent regulatory compliance, public company and operational expertise. For more information, please visit us at www.ausacap.com.
Forward looking statements
This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur and include, but are not limited to: statements in respect of the timing and details of the Distribution, the financial prospects of Australis, the listing of Australis Shares and Warrants on the CSE and the terms of the Restricted Back-in Right. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. Investors should refer to the final prospectus filed by Australis in connection with the Distribution for more information, in particular the risk factors described therein under the heading "Risk Factors". The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Neither TSX nor its Regulation Services Provider (as that term is defined in the policies of Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE Aurora Cannabis Inc.
View original content: http://www.newswire.ca/en/releases/archive/September2018/19/c6481.html
SOURCE: Aurora Cannabis Inc.
For Media: Heather MacGregor, +1.416.509.5416, heather.macgregor@auroramj.com; For
Investors: Marc Lakmaaker, +1.647.269.5523, marc.lakmaaker@auroramj.com; Rob Kelly,
+1.647.331.7228, rob.kelly@auroramj.com; U.S. Investors, Phil Carlson / Elizabeth
Barker, KCSA Strategic Communications, Phone: (212) 896-1233 / (212) 896-1203, Email:
pcarlson@kcsa.com / ebarker@kcsa.com; Australis Contact, Scott Dowty, Chief Executive
Officer, IR@ausacap.com
Copyright (C) 2018 CNW Group. All rights reserved.
MT Newswires Click for Restrictions.
in the last 24 hrs.
Aurora Cannabis Responds to Media Reports Concerning Rumoured Partnership with Beverage Cos; Shares To Resume Trading at 10.45am ET
18 Sep 2018 10:24 ET
10:24 AM EDT, 09/18/2018 (MT Newswires) -- Aurora Cannabis Inc. (ACB.TO) -- with its shares in a trading halt until 10.45am ET -- responded Tuesday to a request from the Investment Industry Regulatory Organization of Canada regarding media reports with respect to potential partnerships with multiple beverage companies. The company said its policy is not to comment on speculative media reports. The company does confirm that it engages in exploratory discussions with industry participants from time to time. At this time the company confirms there is no agreement, understanding or arrangement with respect to any partnership with a beverage company.
A statement said: "In accordance with applicable disclosure requirements, Aurora will advise the market of material changes when they occur."
However, Aurora's chief executive told BNN Bloomberg on Monday that the company has held discussions with at least three beverage companies in the past three months. This came after BNN Bloomberg reported that the Edmonton-based pot firm is in talks with Coca-Cola Co. to develop cannabis-infused drinks.
Price: 9.98, Change: 0.00, Percent Change: 0.00
CTT Pharmaceuticals Appoints Aurora Nominee Dr. Jason Dyck to Board of Directors
12 Jul 2018 08:00 ET
GlobeNewswire
CTT Pharmaceutical Holdings, Inc., (the "Company" or "CTT") (OTC:CTTH), an innovative life sciences company with an extensive portfolio of IP in novel drug delivery systems, is pleased to announce that it has accepted the nomination by Aurora Cannabis Inc. (Aurora) of Dr. Jason Dyck to its Board of Directors. The appointment follows a strategic investment made by Aurora that provides Aurora with the right to nominate two directors to the board of CTT, with the first nominee upon the initial investment, and the second when Aurora increases its ownership in CTT to 42.5%.
Dr. Dyck is a Professor in the Department of Pediatrics at the University of Alberta and a Canada Research Chair in Molecular Medicine. In addition, Dr. Dyck is the Director of the Cardiovascular Research Centre and the co-director of the Alberta HEART, which is a province-wide heart failure research program. Dr. Dyck is also an original Director on the Board of Aurora Cannabis, one of the world's largest cannabis companies, where he provides board oversight for Aurora's scientific efforts.
"We are very pleased being able to appoint someone of Dr. Dyck's caliber, who brings a wealth of medical scientific insights, as well as deep experience in the cannabis industry through his board position at Aurora," said Dr. Pankaj Modi, President & CEO of CTT. "We are building a strong portfolio of IP-protected, novel drug delivery technologies, and the added depth Dr. Dyck brings to our Board, we believe, will contribute to further industry-leading technological developments."
Dr. Dyck, added, "CTT is built on rigorous science and strong, commercially-driven product development capabilities, which I consider two critical success factors in the development of early stage companies, such as CTT. I am excited to take on this new role and help CTT further develop its potential as an important innovator in the cannabis and wider pharmaceutical sector."
About CTT Pharmaceutical Holdings, Inc.
CTTH's principal asset is a unique and novel patented drug delivery technology, an orally administered, fast dissolving thin film (the "Wafer"). This technology platform will target both the human and veterinarian (pet) markets for treatment of many diseases. The Company believes that its Wafer technology will be one of the first to gain use in major markets such as pain management. The Oral Thin Film (Wafer) formulation is protected by several Canadian and U.S. patents.
CTTH's oral fast dissolving drug delivery systems consist of wafers that dissolve without water and within a few seconds after placement in the mouth. The majority of drugs administered using our drug delivery system mirror injections in that they have the ability to enter the bloodstream quickly, are convenient and discrete, and can be administered anywhere. A faster absorption rate is achieved because the mouth contains a very thin mucosa and is extremely vascular. There is no bitter taste; no smoke inhalation as is the case with cannabis; less degradation of medication (by bypassing the stomach) and most importantly lower dosage units are required given the efficacy of absorption. Patient compliance is especially improved with those who have a fear of choking or difficulty swallowing, and/or are pediatric, geriatric or incapacitated.
Aurora Cannabis Inc. has made a strategic investment in in CTT by way of a non-brokered private placement in the form of a US$1 million 5% convertible debenture. The agreement includes an issuance of warrants enabling Aurora to increase its ownership to 42.5%.
For more information, please visit our website:www.cttpharmaceuticals.com
CTT's common shares trade on the OTC market in the United States under the symbol "CTTH".
Notice Regarding Forward-Looking Statements
This news release contains forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements." Forward-looking statements can be identified by the use of words such as "plans", "expects" or "does not expect," "is expected," "estimates," "intends," "anticipates" or "does not anticipate," or "believes", or variations of such words and phrases or state that certain actions, events or results "may," "could," "would," "might" or "will" be taken, occur, or be achieved.
Forward-looking statements are based on assumptions and involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including our future sales, income, and financial position. The forward-looking statements included in this news release are made as of the date of this news release and CTT not undertake to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise, unless required by applicable securities law.
For more information please contact:
Cam Birge
info@cttpharmaceuticals.com
(800) 516-1635
<img src="http://www.globenewswire.com/newsroom/ti?ndecode=MTUwIzczMjYyMDI=" alt="" width="1" height="1"/>
(C) Copyright 2018 GlobeNewswire, Inc. All rights reserved.
MT Newswires Click for Restrictions.
The Green Organic Dutchman Letter to Shareholders
09 Jul 2018 08:00 ET
GlobeNewswire
The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TSX:TGOD)(US:TGODF) is a company built on innovation with the goal of becoming the largest organic cannabis producer in the world. The path is clearly evident from the way we have financed the Company with our retail first approach, to our strategic hires, recent expansion, exclusive licensing deals, entering international markets and most importantly, TGOD's organic differentiation.
The transition from Mr. Robert Anderson to myself although abrupt and untimely, was one that was a planned evolution before the end of the year. As TGOD moves into full production Rob was to move into the executive Chair position providing vision and supporting financing activities. My experience of more than 26 years at senior levels of companies such as Proctor and Gamble running multiple international consumer packed goods operations was his choice for succession to take TGOD to the worldwide markets as the leading organic brand.
Rob had a vision, a vision of doing things the right way, a vision that retail investors have the ability to be so much more than just shareholders. They can become patients of the medical market, customers of the recreational market and brand ambassadors. These are cannabis enthusiasts, advocates, consumers, and from day one TGOD has aimed to empower those passionate about cannabis to invest alongside the management team and create the largest organic cannabis brand in the world. A large portion of what has made TGOD so special today is that vision, and it's that same vision, that same philosophy, that I want to continue delivering for TGOD and TGOD's shareholders. That was Rob's vision, and that is my vision.
Everyone at TGOD would like to sincerely wish Rob a full and swift recovery. He has done so much for our Company, driven us forward at a rapid pace and established an incredible management team to succeed. I am grateful Rob will remain available to advise us as needed. With the condition he is cleared medically, it is anticipated he would come back to join the TGOD family in a senior position. Our plan is in place, the path is paved, and we will not deviate.
TGOD possesses one of the most well-rounded, driven and experienced management teams in the industry. Our board of directors has significant corporate experience specific to consumer-packaged goods, consumer products, and finance including experience in multiple successful acquisitions. Our leadership team has skillsets in all aspects of business including financial management, international markets, mergers & acquisitions, operations, project management, marketing, branding, and sales for some of the largest companies on the planet including Proctor & Gamble, Cott and Weightwatchers. We are focused on becoming the Wholefoods of the cannabis industry and recognized as pioneers in THC/CBD infused beverage industry.
As I transition into the CEO role, it comes down to operations and building a brand. A few recent highlights include:
? Strong cash position: $300 million
? Ontario Cultivation: 150,000 sq. ft. facility in Hamilton under construction, scheduled to open in the first quarter of 2019, capable of producing 14,000 kgs of premium organic cannabis
? Quebec Cultivation: 820,000 sq. ft. facility in Valleyfield under construction, scheduled to open in the first half of 2019 capable of producing 142,000 kgs of premium organic cannabis (Visit www.tgod.ca to see the latest construction videos)
? Jamaican JV: with Epican Medicinals Ltd., capable of producing an additional 14,000 kgs of premium organic cannabis. Jamaica represents the first of many strategic partnerships we intend to execute in the coming months and includes licenses for: cultivation, extraction, manufacturing, and retail distribution
? Denmark JV: with Queen Genetics, & Knud Jepsen adding the potential for an additional 25,000 kgs funded capacity, bringing TGOD European cultivation, R&D and a distribution centre.
? 170,000 kg funded capacity, with potential for 195,000 kg (upon completion of definitive agreement with Denmark JV)
? Aurora Cannabis, Strategic partner: Aurora (TSX:ACB) is the largest, most innovative cannabis company in the world. They invested over $78.1 million into our Company, validating everything from our organic strategy, to our R&D & beverage divisions, to our management team and international expansion plans. Our partnership is truly unique and our respect for Terry Booth and his team is great. In addition, we are fortunate to have Cam Battley, Aurora's CCO, one of the most respected industry leaders, sit on our Board of Directors.
? Largest ETF Holding: We are recognized as the #1 holding in the largest cannabis ETF in the United States
? Licensing partnerships: US states have become landlocked. We can export IP, and license various technologies using our land and our licenses to manufacture branded products in Canada, and own the international sales and distribution channels.
-- Stillwater's, Ripple SC: soluble cannabinoids
-- Evolab: the number one selling vaporizer in Colorado
-- CBx Sciences: medical and recreational cannabis products, R&D and cannabis specific IP
? Launch of strategic Beverage Science and Research Division, 40,000 kg annual capacity cultivation facility dedicated to beverage, and appointment of Prem Virmani as beverage science and research division chair. Prem is the former senior vice-president of global science and research for Cott Beverages Inc.
? Developing a beverage platform moving us into much higher margin products for the future. Our team has over 125-years executive experience in consumer-packaged goods, beverage, and beverage alcohol, more than any other company in the industry
? Cultivation License: for Valleyfield granted & Oils license for Hamilton granted.
? $25 million bought deal @$6.40
? Largest IPO in Cannabis history, raising $132.1 million and listing on the world's premier exchange for cannabis companies, the Toronto Stock Exchange
? Certified Organic product and process by Eco-Cert
? Focus on executing with excellence
TGOD is committed to building the largest organic cannabis brand in the world. Organic is a lifestyle choice, and everything we are building stands for organic. From our Eco-cert organic certification, to our LEED certified construction and GMP compliant facilities. We are committed to sustainability and reducing our carbon footprint by developing some of the most advanced, automated hybrid facilities in existence, helping us produce the highest quality cannabis for the lowest possible cost.
By leveraging our combined experience, we plan to secure additional partnerships, joint ventures, and licensing arrangements with companies across varying jurisdictions in the United States and international markets. We will set up cultivation around the world for domestic, and international expansion. We will utilize our experience in the beverage and alcohol beverage industries to provide a strategic pathway into the cannabis market for large-scale beverage companies by way of direct investment, joint venture or other suitable opportunities. With one of the most dedicated, hard-working and well-rounded teams in the cannabis industry, and we will continue to execute on the business plan. Our plan is in place, the path is paved, and we will not deviate.
In closing, some of Rob's greatest insights, vision and projects have yet to come to conclusion and as the new CEO I plan to execute them as soon as possible which should lead to many exciting days ahead.
Brian Athaide, CEO
The Green Organic Dutchman
ABOUT THE GREEN ORGANIC DUTCHMAN HOLDINGS LTD.
The Green Organic Dutchman Holdings Ltd. is a research & development company licensed under the Access to Cannabis for Medical Purposes Regulations ("ACMPR") to cultivate medical cannabis. The Company carries out its principal activities producing cannabis from its facilities in Ancaster, Ont., pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada) and its regulations.
The Company grows high quality, organic cannabis with sustainable, all-natural principles. TGOD's products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a funded capacity of 170,000 kg of cultivation facilities in Ontario and Quebec and Jamaica.
The Company has developed a strategic partnership with Aurora Cannabis Inc. (TSX:ACB) whereby Aurora has invested approximately C$78.1 million for an approximate 17.5% stake in TGOD. In addition, the Company has raised approximately C$315 million dollars and has over 20,000 shareholders.
TGOD's common shares and warrants issued under the indenture dated November 1, 2017 trade on the TSX under the symbol "TGOD" and "TGOD.WT", respectively.
CONTACT INFORMATION
Investor Relations
Email: invest@tgod.ca
Phone: 1 (416) 900-7621
www.tgod.ca
Forward-Looking Information Cautionary Statement
This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward looking statements in this release includes statements about the future legalization of recreational cannabis and cannabis-infused products in Canada, statements about future research, development and innovation by the Company, statements about the offering of any particular products by the Company and statements regarding the future performance of the Company. Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Neither TSX nor its Regulation Services Provider (as that term is defined in the policies of Toronto Stock Exchange) accept responsibility for the adequacy or accuracy of this release.
https://resource.globenewswire.com/Resource/Download/5e466a28-c05c-4e7e-a826-03392c11dd1c?size=1
<img src="http://www.globenewswire.com/newsroom/ti?ndecode=MTUwIzczMjQ0MTU=" alt="" width="1" height="1"/>
(C) Copyright 2018 GlobeNewswire, Inc. All rights reserved.
MT Newswires Click for Restrictions.
icron Awarded Industrial Design Certificate of Registration for Food and Cannabis Waste Digester
09 Jul 2018 07:00 ET
GlobeNewswire
Micron Waste Technologies Inc. (the "Company") (CSE:MWM) (OTC:MICWF) (Frankfurt:7FM2), a leading developer of aerobic digester solutions for the treatment of organic food and cannabis waste, has been awarded an Industrial Design Certificate of Registration from the Canadian Intellectual Property Office (CIPO) for its commercial Organic Waste Digester Unit. Micron's Application Number 177758 sought and won intellectual property protection for innovative features unique to Micron's unit, which processes both food waste and cannabis plant waste on a commercial scale. The Company's design patent is also pending in the United States.
The CIPO design patent is valid for five years with an option to renew for an additional five years of exclusivity. The new functional design enhances food waste digestion efficiency by up to 40% while reducing the machine's footprint and waste digestion time. The patent-pending technology was repurposed for Micron's Cannabis Waste Digester. The Company's first Cannabis Waste Digester unit was delivered to Aurora Cannabis Inc.'s ("Aurora") (TSX:ACB) Mountain facility outside Calgary, Alberta on June 28, 2018. At 55,200 square foot Aurora Mountain, which produces 4,800 kg of premium cannabis each year, the unit will undergo final site installation and calibration to match production cycles.
The Cannabis Waste Digester, an industrial-grade organic waste processor, pulverizes and renders organic waste in combination with a proprietary blend of microbes and enzymes designed and developed by Micron. Importantly, as part of Micron's full-system waste treatment platform, effluent from the digester is further treated to derive clean greywater which can be re-used in industrial or agricultural operations. Alternatively, the treated regulatory-compliant greywater from the Cannabis Waste Digester, which meets municipal discharge standards, can be safely discharged. Active pharmaceutical compounds in cannabis waste are further biologically treated to denature cannabinoids present, keeping them out of waste streams.
"Receipt of the CIPO Industrial Design Certificate is further testament to Micron's innovation in agricultural and organic waste processing biotechnology and engineering," said Micron President Alfred Wong. "It has always been Micron's intention to create a system that was not only best-in-class, but one that re-invented that class entirely. Our platform marries organic waste digestion with water reclamation and purification to solve our customers' waste processing needs cleanly, cost-effectively and without dumping effluent downstream where it causes problems for municipal waste treatments pla
CSE-listed Choom Secures Aurora Cannabis as $7 Mln Cornerstone Investor
13 Jun 2018 09:48 ET
09:48 AM EDT, 06/13/2018 (MT Newswires) -- Choom (CSE: CHOO) announced Wednesday a non-brokered private placement for gross proceeds of up to $10 million, including a $7 million lead order from Aurora Cannabis Inc. (ACB.TO). It said the private placement will consist of up to 14,084,507 common shares at a price of $0.71 per share and is expected to close on June 18, 2018.
Meanwhile, Bloomberg reported Wednesday that Canadian Prime Minister Justin Trudeau's government is sending his legal marijuana law back to the Senate in what are likely the final procedural steps that could see the bill be approved in coming days.
Price: 8.92, Change: +0.06, Percent Change: +0.68